Literature DB >> 1707980

Evidence that less-than-full-length pol gene products are functional in hepadnavirus DNA synthesis.

T T Wu1, L D Condreay, L Coates, C Aldrich, W Mason.   

Abstract

Duck hepatitis B virus mutants containing frameshift or stop codon mutations in a portion of the viral pol gene separating the terminal protein and reverse transcriptase domains had a leaky phenotype and, depending on the location and type of mutation, synthesized up to 10% as much viral DNA as did the wild type. This region of the pol gene had previously been reported to be refractory to missense mutations; in fact, the leakiness of most of our mutants appeared attributable to translational suppression, which would also be expected to introduce amino acid changes. However, at least one mutant (pH1093 + 2), which was ca. 10% as active as the wild type, appeared to use a novel pathway to express the viral pol gene. Our analyses indicated that pH1093 + 2 synthesized the viral reverse transcriptase as a fusion protein with the amino-terminal portion of the pre-S envelope protein. Thus, in this case, the products of the terminal-protein and reverse transcriptase domains of the pol gene would function as separate protein species, though perhaps noncovalently joined in a dimeric structure during assembly of DNA replication complexes. Evidence was also obtained that was consistent with the idea that the wild-type pol gene may, at least in certain instances, be expressed as functional, subgenic polypeptides.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1707980      PMCID: PMC240562     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Evidence that a capped oligoribonucleotide is the primer for duck hepatitis B virus plus-strand DNA synthesis.

Authors:  J M Lien; C E Aldrich; W S Mason
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

2.  HIV expression strategies: ribosomal frameshifting is directed by a short sequence in both mammalian and yeast systems.

Authors:  W Wilson; M Braddock; S E Adams; P D Rathjen; S M Kingsman; A J Kingsman
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

3.  Molecular analysis of the function of direct repeats and a polypurine tract for plus-strand DNA priming in woodchuck hepatitis virus.

Authors:  C Seeger; J Maragos
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

4.  Expression of the precore region of an avian hepatitis B virus is not required for viral replication.

Authors:  C Chang; G Enders; R Sprengel; N Peters; H E Varmus; D Ganem
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

5.  Duck hepatitis B virus (DHBV) particles produced by transient expression of DHBV DNA in a human hepatoma cell line are infectious in vitro.

Authors:  J C Pugh; K Yaginuma; K Koike; J Summers
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

6.  Detection and mapping of spliced RNA from a human hepatoma cell line transfected with the hepatitis B virus genome.

Authors:  T Suzuki; N Masui; K Kajino; I Saito; T Miyamura
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

7.  The duck hepatitis B virus P-gene codes for protein strongly associated with the 5'-end of the viral DNA minus strand.

Authors:  V Bosch; R Bartenschlager; G Radziwill; H Schaller
Journal:  Virology       Date:  1988-10       Impact factor: 3.616

8.  Hepatitis B virus transcript produced by RNA splicing.

Authors:  T S Su; C J Lai; J L Huang; L H Lin; Y K Yauk; C M Chang; S J Lo; S H Han
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

9.  Transcripts and the putative RNA pregenome of duck hepatitis B virus: implications for reverse transcription.

Authors:  M Büscher; W Reiser; H Will; H Schaller
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

10.  Signals for ribosomal frameshifting in the Rous sarcoma virus gag-pol region.

Authors:  T Jacks; H D Madhani; F R Masiarz; H E Varmus
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

View more
  11 in total

1.  Does a cdc2 kinase-like recognition motif on the core protein of hepadnaviruses regulate assembly and disintegration of capsids?

Authors:  M I Barrasa; J T Guo; J Saputelli; W S Mason; C Seeger
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Regulation of hepadnavirus reverse transcription by dynamic nucleocapsid phosphorylation.

Authors:  Suresh H Basagoudanavar; David H Perlman; Jianming Hu
Journal:  J Virol       Date:  2006-11-29       Impact factor: 5.103

3.  Infection initiated by the RNA pregenome of a DNA virus.

Authors:  M J Huang; J Summers
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

4.  Novel mechanism for reverse transcription in hepatitis B viruses.

Authors:  G H Wang; C Seeger
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

5.  Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase.

Authors:  J Hu; C Seeger
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

6.  Formation of hepatitis B virus covalently closed circular DNA: removal of genome-linked protein.

Authors:  Weifan Gao; Jianming Hu
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

7.  Transcomplementation of nucleotide priming and reverse transcription between independently expressed TP and RT domains of the hepatitis B virus reverse transcriptase.

Authors:  R E Lanford; L Notvall; H Lee; B Beames
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

8.  Detection of DNA polymerase activities associated with purified duck hepatitis B virus core particles by using an activity gel assay.

Authors:  S M Oberhaus; J E Newbold
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

9.  Rolling circle amplification, a powerful tool for genetic and functional studies of complete hepatitis B virus genomes from low-level infections and for directly probing covalently closed circular DNA.

Authors:  Séverine Margeridon; Sandra Carrouée-Durantel; Isabelle Chemin; Luc Barraud; Fabien Zoulim; Christian Trépo; Alan Kay
Journal:  Antimicrob Agents Chemother       Date:  2008-07-07       Impact factor: 5.191

10.  Identification of factor-binding sites in the duck hepatitis B virus enhancer and in vivo effects of enhancer mutations.

Authors:  C Liu; W S Mason; J B Burch
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.